Weinstein Company Sale Delayed by N.Y. Attorney General Lawsuit
Weinstein Company Sale Delayed by N.Y. Attorney General Lawsuit
(In the past, the Weinsteins called him their “third brother.”)
Mr. Schneiderman’s lawsuit does not name Mr. Glasser, who is the chief operating officer, but it refers to him by his title and says
that the sale of the company could result in employees reporting to some of the same managers “who failed to investigate” Mr. Weinstein’s conduct or protect female employees from him.
It says that two employees described having to procure injectable erectile dysfunction medication for Mr. Weinstein and says
that one of them received a bonus for obtaining the medication “and was at times directed by HW to administer the injections.”
The court filing mentions the possible sale of the company, saying
that it could leave victims “without adequate redress” and could provide financial benefits to Mr. Weinstein or his enablers.
Benjamin Brafman, a lawyer for Mr. Weinstein, said in a statement, “While Mr. Weinstein’s behavior was not without fault, there certainly was no criminality, and at the end of the inquiry it will be clear
that Harvey Weinstein promoted more women to key executive positions than any other industry leader.” Mr. Weinstein has denied all allegations of “non-consensual sex.”
Amy Spitalnick, the press secretary for Mr. Schneiderman, said
that his office had recently reached out to representatives for Ms. Contreras-Sweet to emphasize the importance of adequately compensating victims, protecting employees and not rewarding those who enabled or perpetuated Mr. Weinstein’s misconduct.
The lawsuit, which refers to Harvey Weinstein by his initials, says
that the company’s management and board of directors “were repeatedly presented with credible evidence of HW’s sexual harassment” of company employees and interns “and his use of corporate employees and resources to facilitate sexual activity with third parties.”
In one instance, a woman who complained to human resources later discovered that it was forwarded by email to Mr. Weinstein, the legal papers say.
(In the past, the Weinsteins called him their “third brother.”)
Mr. Schneiderman’s lawsuit does not name Mr. Glasser, who is the chief operating officer, but it refers to him by his title and says
that the sale of the company could result in employees reporting to some of the same managers “who failed to investigate” Mr. Weinstein’s conduct or protect female employees from him.
It says that two employees described having to procure injectable erectile dysfunction medication for Mr. Weinstein and says
that one of them received a bonus for obtaining the medication “and was at times directed by HW to administer the injections.”
The court filing mentions the possible sale of the company, saying
that it could leave victims “without adequate redress” and could provide financial benefits to Mr. Weinstein or his enablers.
Benjamin Brafman, a lawyer for Mr. Weinstein, said in a statement, “While Mr. Weinstein’s behavior was not without fault, there certainly was no criminality, and at the end of the inquiry it will be clear
that Harvey Weinstein promoted more women to key executive positions than any other industry leader.” Mr. Weinstein has denied all allegations of “non-consensual sex.”
Amy Spitalnick, the press secretary for Mr. Schneiderman, said
that his office had recently reached out to representatives for Ms. Contreras-Sweet to emphasize the importance of adequately compensating victims, protecting employees and not rewarding those who enabled or perpetuated Mr. Weinstein’s misconduct.
The lawsuit, which refers to Harvey Weinstein by his initials, says
that the company’s management and board of directors “were repeatedly presented with credible evidence of HW’s sexual harassment” of company employees and interns “and his use of corporate employees and resources to facilitate sexual activity with third parties.”
In one instance, a woman who complained to human resources later discovered that it was forwarded by email to Mr. Weinstein, the legal papers say.